摘要
研究新型干扰素hIFN-λ1和hIFN-ε基因在WI-38细胞中的表达及其生物学活性,并进行对比分析。构建His重组融合表达载体pcDNA3.1A-hIFN-λ1-His和pcDNA3.1A-hIFN-ε-His,脂质体法分别转染WI-38人胚肺细胞。采用微量细胞病变抑制试验研究和比较rhIFN-λ1-His和rhIFN-ε-His的抗病毒活性;MTT法检测其对肿瘤细胞生长的影响; RT-PCR相对定量法检测其诱导WI-38和SHG-44细胞产生人MxA抗病毒蛋白的活性。结果表明rhIFN-λ1-His抗病毒活性、抗肿瘤细胞增殖活性和诱导产生MxA蛋白活性要强于rhIFN-ε-His。hIFN-λ1和hIFN-ε干扰素的抗病毒效应的分子机理均与诱导细胞产生MxA抗病毒蛋白相关。为进一步探讨和比较hIFN-λ1和hIFN-ε的生物学活性及其作用机制奠定了一定的基础。
The biological activities i. e. antineoplastic activities and antiviral activity of the two novel kinds of interferons： hIFN-λ1 and hIFN-ε were studied and compared. First the fusion expression vector： pcDNA3.1A-hIFN-λ1-His and pcDNA3.1A -hIFN -ε-His by PCR was constructed, then the two kinds of plasmids were transfected into WI-38 （human embryonic lung cells ） with liposome. And cytopathic effect （CPE） suppression test was used to study and compare the antiviral activities of rhIFN-λ1-His and rhIFN-ε-His, meanwhile MTT assay was used to detect their antineoplastic activities. It was found that, antiproliferative activity and MxA protein induction shown by rhIFN-λ1-His is more powerful than of rhIFN-ε-His. The antiviral molecular mechanisms of both hIFN-λ1 and hIFN-ε are related to MxA. The foundation for further study on the bioactivities and mechanism of action of hIFN-λ1 and hIFN-ε was established.
出处
《中国生物工程杂志》
CAS
CSCD
北大核心
2007年第3期24-33,共10页
China Biotechnology
